Cite

HARVARD Citation

    Bessonova, L. et al. (2018). Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Thorax. 73 (8), pp. 731-740. [Online]. 
  
Back to record